Cas:119434-75-2 Boc-L-4-Thiazolylalanine manufacturer & supplier

Chemical Name:Boc-L-4-Thiazolylalanine

CAS.NO:119434-75-2

Synonyms:Boc-L-4-Thiazoylalanine;N-(tert-butyloxycarbonyl)-3-(4-thiazolyl)-L-alanine;N-(t-butoxycarbonyl)-3-(4-thiazolyl)-L-alanine;N-(tert-butoxycarbonyl)-3-(1,3-thiazol-4-yl)-L-alanine;N-{[(2-Methyl-2-propanyl)oxy]carbonyl}-3-(1,3-thiazol-4-yl)-L-alanine;RARECHEM BK PT 0199;(2S)-2-[(tert-butoxycarbonyl)amino]-3-(thiazol-4-yl)propanoic acid;(S)-3-(4-thiazolyl)-2-tert-butoxycarbonylaminopropanoic acid;N-tert-Butoxycarbonyl-L-(4-thiazolyl)alanine;(S)-2-((tert-Butoxycarbonyl)amino)-3-(thiazol-4-yl)propanoic acid;BOC-S-THZALA-OH;Boc-3-(4-Thiazolyl)-L-alanine;BOC-L-4-THIAZOLYALANINE;BOC-ALA(4-THZ)-OH;Boc-thiazolylalanine;BOC-ALA(4-THIAZOYL)-OH;4-Thiazolepropanoic acid, α-[[(1,1-dimethylethoxy)carbonyl]amino]-, (αS)-;MFCD00079682;L-Alanine, N-[(1,1-dimethylethoxy)carbonyl]-N-4-thiazolyl-;BOC-ALA(4-THIAZOLYL)-OH;N-{[(2-Methyl-2-propanyl)oxy]carbonyl}-N-1,3-thiazol-4-yl-L-alanine;(S)-N-BOC-4-Thiazoylalanine

Molecular Formula:C₁₁H₁₆N₂O₄S

Molecular Weight:272.321

HS Code:2934100090

Physical and Chemical Properties:

Melting point:122℃

Boiling point:415.4±25.0 °C at 760 mmHg

Density:1.3±0.1 g/cm3

Index of Refraction:1.570

PSA:116.76000

Exact Mass:272.083069

LogP:2.47

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like Boc-L-4-Thiazoylalanine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(S)-N-BOC-4-Thiazoylalanine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,L-Alanine, N-[(1,1-dimethylethoxy)carbonyl]-N-4-thiazolyl- Use and application,Boc-thiazolylalanine technical grade,usp/ep/jp grade.

Related News: The FDA has granted so-called accelerated approval in more than 250 instances since 1992, mainly for rare diseases or small patient populations that have had no effective treatments available to them. In these cases, the agency requires that drugmakers conduct additional clinical trials to prove their therapy works, or face withdrawal from the market. Boc-L-4-Thiazolylalanine manufacturer As a result, the Company��s platform is uniquely capable of overcoming numerous limitations associated with the production of cell therapies using patient- or donor-sourced cells, which is logistically complex and expensive and is subject to batch-to-batch and cell-to-cell variability that can affect clinical safety and efficacy. Boc-L-4-Thiazolylalanine supplier As the global generic drug market booms and the international API industry accelerates its transfer to developing countries, China and India rely on cost advantages to rapidly grow into major API producers and exporters. Boc-L-4-Thiazolylalanine vendor The quality of the drug substance determines the quality of the preparation, so its quality standards are very strict. Countries around the world have formulated strict national pharmacopoeia standards and quality control methods for their widely used drug substances. Boc-L-4-Thiazolylalanine factory The FDA has granted so-called accelerated approval in more than 250 instances since 1992, mainly for rare diseases or small patient populations that have had no effective treatments available to them. In these cases, the agency requires that drugmakers conduct additional clinical trials to prove their therapy works, or face withdrawal from the market.